State Street SPDR S&P Biotech ETF (XBI) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- Broad Market / FactorSector
- $169.5552W High
- $89.8552W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track State Street SPDR S&P Biotech ETF (XBI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, State Street SPDR S&P Biotech ETF has traded between a low of $89.85 and a high of $169.55, highlighting its annual price range. Buy and sell State Street SPDR S&P Biotech ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Most Recent News
BP shifts assets and invests in Brazil amid mixed analyst ratings.
BP, a major global energy company, is actively managing its portfolio by potentially selling oil and gas assets in Egypt to Energean and investing in new projects like a Halliburton contract in Brazil's offshore field. This strategic move aims to enh...

Ecopetrol appoints acting VPs and directors as current executives transition out by August 30, 2026.
Ecopetrol announced that several of its current vice presidents and directors will conclude their duties by August 30, 2026. Acting replacements from within the company will assume these roles starting August 31, 2026. The company will later announce...

Investigation launched into Noble Corp for alleged securities fraud after Q2 earnings miss.
Pomerantz LLP is investigating Noble Corporation and some of its executives for potential securities fraud following the company's Q2 2026 financial report. Noble disclosed a $43 million loss due to rig suspensions in Brazil and lowered its full-year...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.